• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

CyDex

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · January 26, 2011

CyDex Pharmaceuticals Approves Merger with Ligand Pharmaceuticals

Transaction Closed Today Expected to Accelerate Development of CyDex’s Captisol® Franchise LENEXA, Kansas – January 26, 2011 – CyDex Pharmaceuticals, Inc. today announced that its stockholders have …

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact